-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Generate Biomedicines with Overweight Rating

Benzinga·03/24/2026 11:44:49
Listen to the news
Cantor Fitzgerald analyst Eric Schmidt initiates coverage on Generate Biomedicines (NASDAQ:GENB) with a Overweight rating.